Back to funds

Squadron Capital Management LLC

Updated 6 days ago

Managed by Squadron Capital Management Llc • Latest filing Q3 2026

Portfolio value
$398.5M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
84.7%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$236M
Q1 2026$272.9M
Q2 2026$322.2M
Q3 2026$398.5M

Top holdings

45 positions as of Q3 2026

View filing
K

KODIAK SCIENCES INC

Value
$39.8M
Shares
420.0K
% Port
9.99%
B

C4 THERAPEUTICS INC

Value
$31M
Shares
9.32M
% Port
7.79%
C

COGENT BIOSCIENCES INC

Value
$29.3M
Shares
915.0K
% Port
7.35%
K

KODIAK SCIENCES INC

Value
$25.6M
Shares
270.0K
% Port
6.42%
S

SILENCE THERAPEUTICS PLC

Value
$22.8M
Shares
2.08M
% Port
5.72%
?
6.N/A

ZENTALIS PHARMACEUTICALS INC

Value
$18.9M
Shares
6.83M
% Port
4.75%
E

EDGEWISE THERAPEUTICS INC

Value
$17.3M
Shares
425.0K
% Port
4.33%
R

RELAY THERAPEUTICS INC

Value
$14.2M
Shares
785.0K
% Port
3.56%
O

ORIC PHARMACEUTICALS INC

Value
$13.5M
Shares
1.00M
% Port
3.38%
R

RELMADA THERAPEUTICS INC

Value
$13.2M
Shares
3.50M
% Port
3.31%
D

DEFINIUM THERAPEUTICS INC

Value
$12.9M
Shares
340.0K
% Port
3.25%
P

PHARVARIS N V

Value
$12.7M
Shares
400.0K
% Port
3.18%
A

ADLAI NORTYE GROUP LTD

Value
$12.2M
Shares
764.9K
% Port
3.07%
V

VERA THERAPEUTICS INC

Value
$9.8M
Shares
305.0K
% Port
2.47%
I

INVENTIVA SA

Value
$8.9M
Shares
2.40M
% Port
2.22%
I

DISC MEDICINE INC

Value
$8.8M
Shares
134.5K
% Port
2.21%
C

COGENT BIOSCIENCES INC

Value
$8.5M
Shares
265.0K
% Port
2.13%
A

AVALO THERAPEUTICS INC

Value
$6.9M
Shares
450.0K
% Port
1.73%
A

ACLARIS THERAPEUTICS INC

Value
$6.3M
Shares
1.20M
% Port
1.58%
R

REZOLUTE INC

Value
$5.5M
Shares
1.32M
% Port
1.38%

Explore